1. When to consider urethrolysis after sling surgery

   • Wendy W. Leng
   • Michael B. Chancellor

   Invited Commentary Pages: 241 - 242

2. Web alert

   • Jaspreet S. Sandhu

   News Pages: 243 - 244

3. Literature alert

   Abstract Pages: 245 - 246

4. The medical therapy of prostatic symptoms trial

   • Kevin T. McVary

   Clinical Trials Report Pages: 249 - 250

5. The relationship between erectile dysfunction and lower urinary tract symptoms: Epidemiological, clinical, and basic science evidence

   • Kevin T. McVary
   • Kevin E. McKenna

   OriginalPaper Pages: 251 - 257

6. Mechanistic insights into the role of α1-adrenergic receptors in lower urinary tract symptoms

   • Gregory A. Michelotti
   • Debra A. Schwinn

   OriginalPaper Pages: 258 - 266

7. The use of baseline clinical measures to predict those at risk for progression of benign prostatic hyperplasia

   • Edward D. Kim

   OriginalPaper Pages: 267 - 273

8. The role of 5-α-reductase inhibition as monotherapy in view of the MTOPS data

   • Jaspreet S. Sandhu
   • Alexis E. Te

   OriginalPaper Pages: 274 - 279

9. Ejaculatory disorders and lower urinary tract symptoms

   • Robert E. Brannigan

   OriginalPaper Pages: 280 - 286

10. Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy

    • Evan R. Eisenberg
    • Gopal H. Badlani

    OriginalPaper Pages: 287 - 294

11. Epidemiology of inflammation and prostate cancer

    • Robert F. Donnell

    Clinical Trials Report Pages: 297 - 297

12. The use of saw palmetto versus finasteride for the treatment of prostatitis/chronic pelvic pain syndrome

    • Robert F. Donnell

    Clinical Trials Report Pages: 298 - 298

13. Multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome

    • Robert F. Donnell

    Clinical Trials Report Pages: 299 - 299

14. Chronic pelvic pain syndrome and voiding dysfunction

    • Werner W. Hochreiter
    • Sebastian Z’Brun

    OriginalPaper Pages: 300 - 304

15. Acupuncture for chronic prostatitis/ chronic pelvic pain syndrome

    • Richard C. T. Chen
    • J. Curtis Nickel

    OriginalPaper Pages: 305 - 308

16. Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men

    • F. M. E. Wagenlehner
    • K. G. Naber

    OriginalPaper Pages: 309 - 316

17. Prostatitis: The cost of disease and therapies to patients and society

    • Pamela L. Schultz
    • Robert F. Donnell

    OriginalPaper Pages: 317 - 319

18. Minimally invasive therapies for prostatitis

    • Peter Zvara
    • Jeffrey B. Folsom
    • Mark K. Plante

    OriginalPaper Pages: 320 - 326